Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Vistagen Therapeutics, Inc. (VTGN)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsMar-31-23Mar-31-22Mar-31-21Mar-31-20Mar-31-19Mar-31-18Mar-31-17Mar-31-16
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues   [+]-0.21.11.10.00.00.01.30.0
            Revenue growth  -120.5%1.8%   -100.0%  
Cost of goods sold  0.00.00.00.00.00.00.00.0
Gross profit  -0.21.11.10.00.00.01.30.0
            Gross margin  100.0%100.0%100.0%   100.0% 
Selling, general and administrative   [+]14.713.57.17.47.56.46.313.9
Research and development  44.435.411.913.417.17.85.23.9
EBITDA   [+]-59.1-47.6-17.8-20.7-24.5-14.1-10.2-17.8
            EBITDA margin  26017.8%-4294.8%-1635.3%   -815.5% 
Depreciation and amortization  0.10.20.10.10.10.10.10.1
EBIT   [+]-59.3-47.8-17.9-20.8-24.6-14.2-10.2-17.9
            EBIT margin  26074.8%-4308.7%-1646.1%   -819.9% 
Interest expense, net   [+]0.00.00.00.00.00.00.00.8
Other income (expense), net   [+]  0.0 0.0-0.1 -28.6
Pre-tax income  -59.2-47.8-17.9-20.8-24.6-14.3-10.3-47.2
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate   0.0%      
Net income  -59.2-48.7-42.3-22.0-25.7-15.6-11.6-51.4
            Net margin  26065.9%-4392.4%-3884.3%   -929.9% 
   
Basic EPS   [+]($8.51)($7.38)($0.49)($0.50)($0.90)($1.12)($1.54)($29.08)
Diluted EPS   [+]($8.51)($7.38)($0.49)($0.50)($0.90)($1.12)($1.54)($29.08)
   
Shares outstanding (basic)   [+]7.06.686.143.928.613.97.51.8
Shares outstanding (diluted)   [+]7.06.686.143.928.613.97.51.8
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy